TSE:4568Pharmaceuticals
Daiichi Sankyo (TSE:4568) Valuation After New Tempus AI Partnership In Antibody Drug Conjugate Oncology
Daiichi Sankyo Company (TSE:4568) shares are in focus after a new collaboration with Tempus AI to apply foundation models and real-world oncology data to an antibody drug conjugate program.
See our latest analysis for Daiichi Sankyo Company.
The AI collaborations, ENHERTU approval in Japan and completion of the latest buyback tranche come as the share price trades at ¥2,930 following a 1 day share price return of 1.93%. However, the 1 year total shareholder return of 19.20% and 3 year total...